Nastaran Bayat
About Nastaran Bayat
Nastaran Bayat is a Clinical Research Assistant at the National Institutes of Health, where she has worked since 2012. She specializes in clinical research protocols related to myositis and has over a decade of experience in studying autoimmune diseases.
Work at National Institutes of Health
Nastaran Bayat has served as a Clinical Research Assistant at the National Institutes of Health (NIH) since 2012. Over the course of 12 years, she has been involved in coordinating clinical research protocols specifically related to myositis, a rare systemic autoimmune disease. Her role includes collaborating with a research group dedicated to investigating the causes and potential treatments for systemic autoimmune diseases. This position has allowed her to contribute significantly to the understanding and management of these complex conditions.
Education and Expertise
Nastaran Bayat earned her Doctor of Medicine (M.D.) degree from Iran University of Medical Sciences, where she studied from 1996 to 2003. This educational background has provided her with a solid foundation in medical science, which she has applied throughout her career in clinical research. Her expertise lies in autoimmune diseases, with a particular focus on myositis, enabling her to contribute effectively to research initiatives aimed at improving patient outcomes.
Background
Nastaran Bayat has over a decade of experience in clinical research, particularly in the field of autoimmune diseases. Her tenure at the National Institutes of Health has been marked by her involvement in various research projects aimed at understanding and treating systemic autoimmune diseases. This extensive background has equipped her with valuable insights into the complexities of autoimmune conditions and the challenges faced in clinical research.
Research Contributions
As part of her role at the National Institutes of Health, Nastaran Bayat is involved in a research group focused on systemic autoimmune diseases. This group explores both the causes and potential treatments for conditions like myositis. Her contributions to this research are integral to advancing knowledge in the field and developing new therapeutic strategies for affected patients.